Lipoprotein Lipase Antikörper (AA 162-246)
Kurzübersicht für Lipoprotein Lipase Antikörper (AA 162-246) (ABIN7158443)
Target
Alle Lipoprotein Lipase (LPL) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 162-246
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Lipoprotein lipase protein (162-246AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: IHC:1:500-1:1000, IF:1:200-1:500,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Lipoprotein Lipase (LPL)
-
Andere Bezeichnung
- LPL
-
Hintergrund
-
Background: The primary function of this lipase is the hydrolysis of triglycerides of circulating chylomicrons and very low density lipoproteins (VLDL) (PubMed:27578112). Binding to heparin sulfate proteogylcans at the cell surface is vital to the function. The apolipoprotein, APOC2, acts as a coactivator of LPL activity in the presence of lipids on the luminal surface of vascular endothelium (By similarity).
Aliases: EC 3.1.1 antibody, EC 3.1.1.34 antibody, HDLCQ11 antibody, LIPD antibody, LIPL_HUMAN antibody, Lipoprotein lipase antibody, LPL antibody, LPL protein antibody, MGC137861 antibody
-
UniProt
- P06858
-
Pathways
- Lipid Metabolism
Target
-